trending Market Intelligence /marketintelligence/en/news-insights/trending/Grq3zVYQISEabL8QxMl7zw2 content esgSubNav
In This List

Kindred Biosciences plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Kindred Biosciences plans common stock offering

Kindred Biosciences Inc. is looking to raise funds for its product pipeline via an underwritten public offering that is yet to be priced.

The San Francisco-based biotechnology company, which is developing medicines for pets, has engaged Barclays Capital Inc. and Stifel as joint book-running managers. The underwriters will have an option to buy additional shares from the company.